Fibroblast growth factor receptor (FGFR) inhibitor rogaratinib in patients with advanced pretreated squamous-cell non-small cell lung cancer over-expressing FGFR mRNA: The SAKK 19/18 phase II study
Titel:
Fibroblast growth factor receptor (FGFR) inhibitor rogaratinib in patients with advanced pretreated squamous-cell non-small cell lung cancer over-expressing FGFR mRNA: The SAKK 19/18 phase II study
Auteur:
Addeo, Alfredo Rothschild, Sacha I. Holer, Lisa Schneider, Martina Waibel, Christine Haefliger, Simon Mark, Michael Fernandez, Eugenio Mach, Nicolas Mauti, Laetitia Jermann, Philip M. Alborelli, Ilaria Calgua, Byron Savic-Prince, Spasenija Joerger, Markus Früh, Martin